证券代码：600299 证券简称：安迪苏 公告编号： 2025-044 蓝星安迪苏股份有限公司 关于股东大会开设网络投票提示服务的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 蓝星安迪苏股份有限公司（以下简称"安迪苏"或"公司"）已于 2025 年 9 月 10 日披露了关于召开 2025 年第三次临时股东大会的通知，拟于 2025 年 9 月 25 日下午 14:00 召开 2025 年第三次临时股东大会，本次会议采用现场投票和网络 投票相结合的表决方式。具体内容详见公司披露于上海证券交易所的公告《安 迪苏关于召开 2025 年第三次临时股东大会的通知》（公告编号：2025-042）。 为更好地服务广大中小投资者，确保有投票意愿的中小投资者能够及时参 会、及时投票。公司拟使用上证所信息网络有限公司（以下简称"上证信息"） 提供的股东大会提醒服务，委托上证信息通过智能短信等形式，根据股权登记 日的股东名册主动提醒股东参会投票，向每一位投资者主动推送股东会参会邀 请、议案情况等信息。投资者在收到智能短信后，可根据使用手册 ...

Core Viewpoint - Andy Su's stock price has experienced a decline of 22.39% year-to-date, with a recent drop of 2.04% on September 15, 2023, indicating potential concerns regarding its market performance and investor sentiment [1]. Financial Performance - For the first half of 2025, Andy Su reported a revenue of 8.512 billion yuan, reflecting a year-on-year growth of 17.23%, and a net profit attributable to shareholders of 740 million yuan, which is a 21.82% increase compared to the previous year [2]. - The company has distributed a total of 4.936 billion yuan in dividends since its A-share listing, with 1.049 billion yuan distributed over the last three years [2]. Shareholder and Market Activity - As of June 30, 2025, the number of shareholders for Andy Su decreased by 5.24% to 32,700, while the average number of circulating shares per person increased by 5.53% to 82,035 shares [2]. - The stock's trading activity on September 15, 2023, showed a net outflow of 8.5654 million yuan from major funds, with significant selling pressure observed [1]. Company Overview - Andy Su, established on May 31, 1999, and listed on April 20, 2000, specializes in the research, production, and sales of animal nutrition additives, with functional products accounting for 76.07% of its revenue and specialty products making up 23.93% [1]. - The company is categorized under the basic chemicals industry, specifically in food and feed additives, and is associated with several concepts including state-owned enterprise reform and vitamins [1].

Group 1 - The stock price of Andy Su (600299) closed at 9.8 yuan on September 12, 2025, reflecting a 0.2% increase from the previous week's 9.78 yuan, with a market capitalization of 26.39 billion yuan [1] - The company ranks 11th out of 169 in the chemical products sector and 709th out of 5153 in the A-share market [1] Group 2 - Andy Su will hold its third extraordinary general meeting of shareholders on September 25, 2025, to discuss several resolutions, including the cancellation of the supervisory board and amendments to the company's articles of association [2] - The meeting will be conducted both in-person and via online voting, with the record date set for September 18, 2025 [2] Group 3 - The company has received approval from the China Securities Regulatory Commission for its application to issue shares to specific targets, with the registration valid for 12 months from the date of approval [3] - The issuance will not change the company's control and has been approved by the Shanghai Stock Exchange [6] Group 4 - Andy Su plans to raise up to 3 billion yuan through the issuance of shares, which will be allocated to various projects, including a solid methionine project and special feed additive projects [5] - The funds will also be used for wastewater treatment and working capital [5]

蓝星安迪苏股份有限公司 向特定对象发行 A 股股票 募集说明书 （注册稿） 保荐人（主承销商） 广东省深圳市福田区中心三路 8 号卓越时代广场（二期） 北座 二〇二五年九月 股票简称：安迪苏 股票代码：600299 蓝星安迪苏股份有限公司 向特定对象发行 A 股股票募集说明书（注册稿） 声 明 本公司及全体董事、监事、高级管理人员承诺募集说明书及其他信息披露 资料不存在任何虚假记载、误导性陈述或重大遗漏，并对其真实性、准确性及 完整性承担连带赔偿责任。 公司负责人、主管会计工作负责人及会计机构负责人保证募集说明书中财 务会计资料真实、完整。 中国证券监督管理委员会、上海证券交易所对本次发行所作的任何决定或 意见，均不表明其对申请文件及所披露信息的真实性、准确性、完整性作出保 证，也不表明其对发行人的盈利能力、投资价值或者对投资者的收益作出实质 性判断或保证。任何与之相反的声明均属虚假不实陈述。 根据《证券法》的规定，证券依法发行后，发行人经营与收益的变化，由 发行人自行负责。投资者自主判断发行人的投资价值，自主作出投资决策，自 行承担证券依法发行后因发行人经营与收益变化或者证券价格变动引致的投资 风险。 1- ...

Core Viewpoint - The approval of Andy Su's 3 billion yuan private placement aims to enhance production capacity and support sustainable development projects, reflecting the company's growth strategy in the animal nutrition sector [1][2]. Fundraising and Business Expansion - Andy Su plans to raise up to 3 billion yuan through a private placement to expand production capacity and supplement working capital [2]. - The funds will be allocated to functional products, special products, and sustainable development projects, with 1.743 billion yuan specifically earmarked for a solid methionine project [2][3]. - The company categorizes its main products into functional products (including methionine and vitamins) and special products (including feed additives) [2]. Market Demand and Growth - The global demand for methionine is projected to reach 1.7 million tons by 2024, with a compound annual growth rate (CAGR) of 4.4%, while China's demand is expected to grow from 280,000 tons in 2019 to 450,000 tons by 2024, with a CAGR of 10% [3]. - The company anticipates strong market absorption for its new production capacity due to this growing demand [3]. Financial Performance - In the first half of 2025, Andy Su reported a revenue increase of 17.23% to 8.512 billion yuan and a net profit increase of 21.82% to 740 million yuan [4]. - The sales of methionine continued to grow, driven by increased market penetration, with a 16% year-on-year increase in sales volume [4]. - The special products segment also saw a revenue increase of 9% to 2.04 billion yuan, supported by strong sales growth in ruminant and pig products [4]. Research and Development - The company is committed to increasing R&D investments in green production, biotechnology, and digital services, with R&D expenses reaching 172 million yuan in the first half of 2025 [5]. - Andy Su operates five global R&D centers with over 300 employees dedicated to research and innovation, which are crucial for supporting its dual pillar strategy [5].

Core Viewpoint - Company received approval from Shanghai Stock Exchange for a specific stock issuance, which is valid for 12 months from the date of approval [1] Group 1: Stock Performance - As of September 11, 2025, the stock price of Andy Su (600299) closed at 9.82 yuan, an increase of 0.31% from the previous trading day [1] - The stock opened at 9.79 yuan, reached a high of 9.83 yuan, and a low of 9.72 yuan, with a trading volume of 82.97 million yuan and a turnover rate of 0.32% [1] Group 2: Regulatory Approval - Company announced on September 9, 2025, that it received the approval from Shanghai Stock Exchange for the registration of stock issuance to specific investors [1] - The approval is documented under the regulatory number (证监许可〔2025〕1970号) and requires the company to strictly follow the submitted application documents and issuance plan [1] - The company is obligated to complete the issuance-related matters within the stipulated timeframe and fulfill information disclosure requirements [1]

Group 1 - Company Wuchan Jinyun plans to reduce its shareholding by up to 3%, amounting to a maximum of 6.24 million shares [1] - Company Hualing Steel's shareholder intends to increase its stake by 1% to 2%, acquiring between 6.91 million and 13.8 million shares [1] - Company Zhujiang Co. plans to sell multiple stock assets, potentially generating over 50% of its audited net profit from the previous year [1] Group 2 - Company Dash Smart's actual controller plans to reduce holdings by up to 1.52%, equating to 30.41 million shares [2] - Company Zhendian Medical's controlling shareholder intends to transfer 5% of its shares, totaling 13.32 million shares, at a price of 26.74 yuan per share [2] - Company Dajin Heavy Industry's subsidiary signed a contract worth approximately 1.25 billion yuan for offshore wind power foundations, representing about 33% of its projected revenue for 2024 [4] Group 3 - Company Andy Su received approval for a stock issuance to specific investors [5] - Company Shield Environment plans to invest approximately 5 billion yuan in a new smart manufacturing headquarters project [7] - Company Dongfang Guoxin intends to establish a joint venture with Shunyi Jin Kong with a registered capital of 300 million yuan [8] Group 4 - Company ST Lian Shi signed a pre-restructuring investment agreement with selected investors, with share prices set at 5.65 yuan and 6.73 yuan for different lock-up periods [9][10] - Company Langzi Co. plans to acquire 67.5% of Chongqing Time for 92.475 million yuan [11] - Company Yingli Co. intends to purchase 77.94% of Youte Li for 468 million yuan and raise up to 196 million yuan through a private placement [13] Group 5 - Company Betta Pharmaceuticals plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange [14] - Company Hehua Co. intends to transfer control by selling 23.76% of its shares for 632 million yuan [16] - Company Jieshun Technology's shareholder plans to reduce holdings by up to 3%, totaling 1.92 million shares [18] Group 6 - Company Wuyang Zikong's controlling shareholder plans to transfer 15% of its shares, changing the controlling party [19] - Company Zhongliang Kegong plans to reduce its shareholding by up to 3%, amounting to 1.54 million shares [20] - Company Changhua Chemical intends to reduce its shareholding by up to 3%, totaling 417,420 shares [22]

安迪苏是一家全球领先的动物营养添加剂企业，主要从事动物营养添加剂的研发、生产及销售。公司股 票9月10日收盘价为9.79元/股。 核校：孙萍 募集资金净额将用于功能性产品项目（15万吨/年固体蛋氨酸项目）、特种产品项目（年产3.7万吨特种 产品饲料添加剂项目、布尔戈斯特种产品饲料添加剂项目）、可持续发展项目（丙烯酸废水处理和中水 回用项目）及补充流动资金。 公司表示，15万吨/年固体蛋氨酸项目将有效扩充中国蛋氨酸产能，优化产品结构及国内外产能布局， 是实施"双支柱"战略、巩固行业领导地位的关键举措。特种产品项目着重降本扩产，落实将特种产品作 为第二大收入驱动因素的战略规划。可持续发展项目旨在减少污染物和降低碳排放，实现节能减排目 标。 本次发行将增强公司资本实力，部分募集资金用于补充流动资金，可优化资产负债结构，缓解经营性现 金流压力，降低财务风险。从长期战略看，资金实力增强有助于公司在产业链布局、新业务开拓、技术 研发创新等方面实现优化，提升主营业务深度及广度。 ...

（文章来源：证券日报） 证券日报网讯 9月10日晚间，安迪苏发布公告称，公司于2025年9月9日收到上海证券交易所出具的《关 于同意蓝星安迪苏股份有限公司向特定对象发行股票注册的批复》（证监许可〔2025〕1970号），主要 内容如下："一、同意你公司向特定对象发行股票的注册申请。二、你公司本次发行应严格按照报送上 海证券交易所的申报文件和发行方案实施。三、本批复自同意注册之日起12个月内有效。四、自同意注 册之日起至本次发行结束前，你公司如发生重大事项，应及时报告上海证券交易所并按有关规定处 理。" ...

证券代码：600299 证券简称：安迪苏 公告编号：2025-043 二、你公司本次发行应严格按照报送上海证券交易所的申报文件和发行方案实施。 三、本批复自同意注册之日起 12 个月内有效。 四、自同意注册之日起至本次发行结束前，你公司如发生重大事项，应及时报告 上海证券交易所并按有关规定处理。" 公司董事会将根据上述批复文件和相关法律、法规的要求及公司股东会的授权， 在规定期限内办理本次向特定对象发行股票相关事宜，并及时履行信息披露义务。敬 请广大投资者注意投资风险。 特此公告。 蓝星安迪苏股份有限公司董事会 关于向特定对象发行股票申请获得中国证券监督管理委员 会同意注册批复的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 蓝星安迪苏股份有限公司（以下简称"公司"）于 2025 年 9 月 9 日收到上海证券交 易所（以下简称"上交所"）出具的《关于同意蓝星安迪苏股份有限公司向特定对象发 行股票注册的批复》（ 证监许可〔2025〕1970 号），主要内容如下： "一、同意你公司向特定对象发行股票的注册申请。 蓝星安迪苏 ...